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ABSTRACT
The protein CHD1 is a member of the family of ATPase-dependent
chromatin remodeling factors. CHD1, which recognizes trimethylated
histone H3 lysine 4, has been implicated in transcriptional activation in
organisms ranging from yeast to humans. It is required for pre-mRNA
maturation, maintenance of mouse embryonic stem cell pluripotency
and rapid growth of the mouse epiblast. However, the function(s) of
CHD1 in mouse preimplantation embryos has not yet been examined.
Here, we show that loss of CHD1 function led to embryonic lethality
after implantation. In mouse embryos in which Chd1 was targeted by
siRNA microinjection, the expression of the key regulators of cell fate
specification Pou5f1 (also known as Oct4), Nanog and Cdx2 was
dramatically decreased, starting atmid-preimplantation geneactivation
(MGA). Moreover, expression of Hmgpi and Klf5, which regulate
Pou5f1,Nanog andCdx2, was also significantly suppressed at zygotic
gene activation (ZGA). Suppression of Hmgpi expression in Chd1-
knockdown embryos continued until the blastocyst stage, whereas
suppression ofKlf5 expressionwas relieved by themorula stage. Next,
we rescued HMGPI expression via Hmgpi mRNA microinjection in
Chd1-knockdown embryos. Consequently, Pou5f1, Nanog and Cdx2
expression was restored at MGA and live offspring were recovered.
These findings indicate that CHD1plays important roles inmouse early
embryogenesis via activation of Hmgpi at ZGA.
KEY WORDS: Chd1, Embryo development, Epigenetics,
Zygotic gene activation, Mouse
INTRODUCTION
During preimplantation development in themouse, the first important
gene expression event is zygotic gene activation (ZGA), the first
transcription from the newly formed zygotic genome, which occurs
between the late 1-cell and 2-cell stages and is required for normal
development (Hamatani et al., 2004;Leveyet al., 1977; Li et al., 2010;
Minami et al., 2007; Schultz, 1993;Wang andDey, 2006;Warner and
Versteegh, 1974). One-cell embryos treatedwithα-amanitin, anRNA
polymerase II inhibitor, arrest development at the 2-cell stage because
ZGA is suppressed (Levey et al., 1977;Warner and Versteegh, 1974).
The second transcriptional event is mid-preimplantation gene
activation (MGA), which occurs between the 4-cell and 8-cell
stages. During this period, genes required for cell fate specification,
such as the transcription factors Pou5f1 (also known asOct4),Nanog
and Cdx2, are expressed; these genes are key regulators governing
formation of the inner cell mass (ICM) and trophectoderm (TE)
(Hamatani et al., 2004;Nichols et al., 1998;Niwa et al., 2005; Strumpf
et al., 2005; Wang and Dey, 2006; Yoshikawa et al., 2006). Thus, to
understand cell fate specification, we must discern the regulatory
mechanisms underlying expression of lineage-specific marker genes
such as Pou5f1, Nanog and Cdx2 at MGA. A previous study showed
that a deficiency of Tead4, a transcription factor expressed during
ZGA in mouse preimplantation embryos, led to a failure of cell fate
specification due to suppression of Cdx2 expression at MGA and
developmental arrest at the morula stage (Yagi et al., 2007). Other
experiments have also identified genes that are involved in cell fate
specification by regulating the expression of Pou5f1, Nanog or Cdx2
(Do et al., 2013; Elling et al., 2006; Home et al., 2012; Strumpf et al.,
2005; Wang et al., 2010; Zhang et al., 2006, 2013).
During preimplantation development in mammals, dynamic
changes occur in chromatin structure (Abdalla et al., 2009; Albert
andHelin, 2010; Burton and Torres-Padilla, 2010; Corry et al., 2009;
Morgan et al., 2005; Rasmussen and Corry, 2010; Shi and Wu,
2009). Previous studies showed that suppression ofBrg1 (Smarca4 –
Mouse Genome Informatics Database), a subclass of switch/sucrose
non-fermentable (SWI/SNF)ATP-dependent chromatin remodelers,
in mouse preimplantation embryos causes widespread expression of
Pou5f1 in the TE and leads to early embryonic death (Kidder et al.,
2009; Wang et al., 2010). This suggests that chromatin-remodeling
factors play important roles in mouse cell fate specification. CHD1
(chromodomain helicase DNA binding protein 1) belongs to the
family of ATPase-dependent chromatin remodeling factors
(Woodage et al., 1997). It recognizes the trimethylated lysine 4 of
histone 3 (H3K4me3) (Sims et al., 2005) and has been implicated in
transcriptional activation in yeast (Simic et al., 2003), Drosophila
(Stokes et al., 1996) andmammalian cells (Sims et al., 2007). CHD1
is involved in pre-mRNA maturation (Sims et al., 2007), the
maintenance of mouse embryonic stem cell (ESC) pluripotency
(Gaspar-Maia et al., 2009), the maintenance of optimal
transcriptional output in mouse ESCs and epiblast cells (Guzman-
Ayala et al., 2015), and incorporation of the variant histoneH3.3 into
paternal pronuclear chromatin at fertilization inDrosophila embryos
(Konev et al., 2007). However, the function(s) of CHD1 in
mammalian preimplantation development is not fully understood.
Here, we investigated whether CHD1 functions during
preimplantation development in the mouse. We observed that Chd1
expression started to increase at the 2-cell stage, CHD1 was intensely
localized innuclei startingat the 2-cell stageand lossofCHD1 function
by siRNA treatment led to embryonic lethality after implantation, due
to suppression of Pou5f1, Nanog and Cdx2 expression at MGA.
Additionally, the expression of Hmgpi and Klf5, which regulate the
expression of Pou5f1,Nanog andCdx2 during mouse preimplantation
development (Ema et al., 2008; Lin et al., 2010; Yamada et al., 2010),
was dramatically suppressed beginning at ZGA. However, HmgpiReceived 30 November 2014; Accepted 14 May 2015
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mRNA microinjection in Chd1-knockdown embryos (Chd1-
knockdown-Hmgpi-rescue embryos) rescued Pou5f1, Nanog and
Cdx2 expression andpostimplantation embryo development. Based on
these results, we propose that CHD1 has important roles in the
developmentofpre- andpostimplantationembryosvia the activationof
Hmgpi expression at ZGA.
RESULTS
Expression and localization of Chd1 during preimplantation
development in the mouse
To investigate the roles of CHD1 during preimplantation
development in the mouse, Chd1 expression and CHD1 localization
were examined in preimplantation embryos (Fig. 1). Chd1 mRNA
was expressed from the 1-cell to the blastocyst stage. Specifically, the
expression increased at the 2-cell stage, peaked at the 8-cell stage and
then dramatically decreased. CHD1 was localized in the nuclei of all
blastomeres during preimplantation development and its staining
intensity increased from the 2-cell stage onward.
Effects of Chd1-knockdown on the development of mouse
embryos
Although the results of qRT-PCRand immunostaining revealed that the
amounts of Chd1 mRNA and protein were dramatically reduced after
the 2-cell stage when siChd1 was injected at the 1-cell stage (Fig. 2),
Fig. 1. Chd1 expression and CHD1 localization during mouse
preimplantation development. (A) qRT-PCR analysis of Chd1mRNA
expression during mouse preimplantation development. Expression levels at
each developmental stage were normalized to H2afz, used as internal control.
ThemRNA levelsof the1-cell embryosweredefinedas1.Dataareexpressedas
means±s.e.m. (n=3). (B) Localization of CHD1 during mouse preimplantation
development (red, CHD1; blue, chromatin). Representative images of embryos
at each stage are shown. Between 20 and 50 embryos were used in each
experiment (n=3): in total, 103, 96, 117, 79, 81 and 124 embryos each for 1-cell,
2-cell, 4-cell, 8-cell, morula and blastocyst stage, respectively.
Fig. 2. EffectsofChd1-knockdownonexpressionofChd1mRNAandprotein
in mouse preimplantation embryos. (A) qRT-PCR analysis of Chd1mRNA
expression in control and Chd1-knockdown embryos from the early 2-cell to the
blastocyst stage (*P<0.05). Expression levels were normalized to H2afz, used as
internal control. ThemRNA levels of the early 2-cell control embryos were defined
as 1. Data are expressed as means±s.e.m. (n=3). (B) Immunofluorescence
detection of CHD1 protein in control and Chd1-knockdown embryos (red,
CHD1; blue, chromatin). Representative images of embryos at each stage are
shown.Each imagecontains oneembryo.Between20and50embryoswere used
in each experiment (n=3): in total, 96, 117, 79, 81 and 124 control embryos and
92, 121, 103, 144 and 137 Chd1-knockdown embryos each for late 2-cell, 4-cell,
8-cell, morula and blastocyst stage, respectively.
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Chd1-knockdown embryos exhibited morphologically normal growth
until the blastocyst stage, andChd1-knockdown blastocysts (E4.5) had
normal numbers of cells in both ICM and TE compared with controls
(Fig. 3). In addition, there were no differences in hatching percentages
between control and Chd1-knockdown embryos (Fig. 3). However,
outgrowth experiments showed that the percentage of ICM-derived
colony formation was dramatically decreased in Chd1-knockdown
embryos (Fig. 3). Furthermore, the litter size after embryo transfer was
significantly reduced in Chd1-knockdown embryos (Table 1).
CHD1regulateszygoticexpressionofPou5f1,NanogandCdx2
CHD1 is required for optimal transcriptional output in mouse ESCs
(Guzman-Ayala et al., 2015).Therefore, to investigate the cause of litter
size reduction inChd1-knockdownembryos,we examined the effect of
Chd1-knockdown on global gene expression in preimplantation
embryos by BrUTP incorporation assay. The results showed that the
reduction of global transcriptional activity does not occur in Chd1-
knockdown embryos at the 2- and 4-cell stages (Fig. 4). To investigate
the cause of litter size reduction inChd1-knockdown embryos further,
we assessed expression of the lineage-specific markers Pou5f1,Nanog
and Cdx2 at the mRNA and protein levels by qRT-PCR and
immunostaining, respectively (Fig. 5). In control embryos, Pou5f1
mRNA levels increased dramatically at the 4- and 8-cell stages, but
subsequently decreased. By contrast, Pou5f1 mRNA expression was
suppressed throughout these stages in Chd1-knockdown embryos. In
control embryos,NanogmRNA levels increased dramatically at the 4-
and 8-cell stages, peaked at the morula stage and then decreased. By
contrast, Nanog mRNA expression was suppressed throughout these
stages in Chd1-knockdown embryos. With respect to Cdx2, in control
embryosmRNAwas first detected at the 8-cell stage and then gradually
increased. Interestingly, Cdx2 mRNA expression was suppressed
during these stages in Chd1-knockdown embryos. Furthermore, in
Chd1-knockdown embryos, immunofluorescence detection of OCT4
(encoded by Pou5f1), NANOG and CDX2 revealed that maternal
OCT4 and NANOG proteins were maintained until the 4-cell stage,
whereas for newly synthesized proteins, OCT4 and NANOG were
reduced starting at the 8-cell stage, and CDX2 was reduced starting at
the morula stage, respectively. The localization of OCT4 in the ICM,
NANOG in the epiblast and CDX2 in the TE did not change in Chd1-
knockdown embryos (Fig. 5).
CHD1 regulates the expression of Hmgpi and Klf5 during
preimplantation development
The mechanisms that regulate Pou5f1, Nanog and Cdx2 expression
during mouse preimplantation development have gradually been
elucidated.However, theonly factors identified todate that regulate the
Fig. 3. Effect of Chd1-knockdown on the development of mouse embryos. (A) Pairs of representative images showing the development of preimplantation
embryos injected with either siControl or siChd1. Embryos were photographed 36 h after in vitro fertilization and at 24-h intervals thereafter. (B) The percentages
of normal development observed at E1.5 (≥2-cell), E2.5 (≥4-cell), E3.5 (≥morula), E4.5 (≥blastocyst) and E5.5 (≥hatching) in control and Chd1-knockdown
embryos. Data are expressed as means±s.e.m. (n=5). Twenty embryos were used in each experiment: in total, 100 embryos each for the siControl and
siChd1 arms. (C) The numbers of ICM and TE cells were assessed by counting OCT4+ cells and CDX2+ cells, respectively. Total numbers of cells were obtained
by combining the numbers of ICM and TE cells. Data are expressed as means±s.e.m. (n=20). (D) Photographs depict representative results of outgrowth
experiments for control andChd1-knockdown embryos. (E) The successful percentage of ICM-derived colony formation in control andChd1-knockdown embryos
after 4 days in culture (*P<0.05). Data are expressed as means±s.e.m. (n=5). Between 25 and 120 embryos were used in each experiment: in total, 284 and
218 embryos for siControl and siChd1, respectively.
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expression of Pou5f1 andNanog in ICM andCdx2 in TE are HMGPI
and KLF5, both of which are transcription factors (Ema et al., 2008;
Lin et al., 2010; Yamada et al., 2010). Therefore,we hypothesized that
CHD1 regulates the expression of Pou5f1 and Nanog in the ICM and
Cdx2 in the TE via activation of Hmgpi and Klf5 expression. To
investigate the effects of CHD1 on Hmgpi and Klf5 expression, the
levels of Hmgpi and Klf5 mRNA and protein in Chd1-knockdown
embryos were examined by qRT-PCR and immunostaining,
respectively (Fig. 6). With respect to Hmgpi, in control embryos
mRNAwas first detected at the late 2-cell stage, peaked at the 4-cell
stage and then gradually decreased. Conversely, Hmgpi mRNA
expression was suppressed during these stages in Chd1-knockdown
embryos. Immunofluorescent (IF) detection of HMGPI protein
determined that its levels were also reduced from the 4-cell stage
onward inChd1-knockdown embryos (Fig. 6).With respect toKlf5, in
control embryos mRNAwas also first detected at the late 2-cell stage,
peaked at the 8-cell stage and was maintained through the blastocyst
stage. On the other hand, in Chd1-knockdown embryos, expression
was suppressed at the 4- and 8-cell stages but recovered after the
morula stage. IF detection of KLF5 demonstrated that the amount of
KLF5 protein was remarkably reduced at the 4- and 8-cell stages;
however, KLF5 protein levels gradually recovered after the morula
stage in Chd1-knockdown embryos (Fig. 6).
HMGPI rescue can recover outgrowth and litter size in Chd1-
knockdown embryos
To investigate whether Hmgpi regulates the expression of Pou5f1,
Nanog and Cdx2 under the control of CHD1, we rescued HMGPI
expression by injecting Hmgpi mRNA into Chd1-knockdown
embryos. Outgrowth and embryo transfer experiments showed that
normal ICM-derived colony formation and litter sizewere recovered
inChd1-knockdown-Hmgpi-rescue embryos (Fig. 7, Table 2). qRT-
PCR results indicated that Chd1 mRNA levels were not restored in
Chd1-knockdown-Hmgpi-rescue embryos at any stage (Fig. 7).
Nonetheless, qRT-PCR and immunostaining results showed that
Pou5f1 and Nanog mRNA levels recovered, starting at the 4-cell
stage onward, and that OCT4 and NANOG protein expression
levels recovered starting at the 8-cell stage onward (because
maternal OCT4 and NANOG proteins remain until the 4-cell stage
in Chd1-knockdown-Hmgpi-rescue embryos). Furthermore, Cdx2
mRNA levels were restored starting at the 8-cell stage onward, and
CDX2 protein levels were recovered starting at the morula stage
onward in Chd1-knockdown-Hmgpi-rescue embryos (Fig. 7).
Meanwhile, qRT-PCR and immunostaining of Klf5 revealed that
HMGPI rescue had no effect on the expression of Klf5 mRNA or
protein (see supplementary material Fig. S1).
DISCUSSION
CHD1, a chromatin remodeling factor, recognizes H3K4me3 (Sims
et al., 2005), facilitates pre-mRNA maturation (Sims et al., 2007)
and is required for the maintenance of mouse ESC pluripotency
(Fazzio and Panning, 2010; Gaspar-Maia et al., 2009). CHD1 is
also necessary at fertilization in Drosophila embryos for the
incorporation of the variant histone H3.3 into paternal pronuclear
chromatin in the absence of transcription (Konev et al., 2007).
Recent work showed that Chd1-knockout embryos undergo
developmental arrest at E6.5 due to a failure to maintain the
epiblast (Guzman-Ayala et al., 2015). However, because Chd1-
knockout embryos were produced from heterozygous intercrosses,
maternal Chd1 mRNA and protein are not suppressed at ZGA in
Chd1-knockout embryos. Here, we showed that in Chd1-
knockdown embryos, expression of Chd1 mRNA and proteins
were suppressed at ZGA, and Chd1 knockdown led to embryonic
lethality after implantation. Additionally, we showed that
suppression of zygotic Pou5f1, Nanog and Cdx2 expression
continued through the blastocyst stage via suppression of Hmgpi.
However, we also showed that CHD1 was not required for global
transcriptional activity at ZGA and MGA, suggesting that CHD1 is
involved in selective regulation of gene expression that governs
normal embryogenesis and the maintenance of pluripotency during
mouse preimplantation development.
The expression of Pou5f1, Nanog and Cdx2 at MGA is regulated
by Hmgpi and Klf5, both of which begin to be expressed at ZGA
(Ema et al., 2008; Lin et al., 2010; Yamada et al., 2010). In embryos
lacking functional Hmgpi or Klf5, developmental arrest occurs
during peri-implantation development due to suppression of
Pou5f1, Nanog and Cdx2 expression (Ema et al., 2008; Lin et al.,
2010; Yamada et al., 2010), suggesting that Hmgpi and Klf5
regulate the initiation of cell fate specification. However, the
detailed mechanisms underlying regulation of Pou5f1, Nanog and
Cdx2 by HMGPI and KLF5 are unknown. The results of this study
showed that in Chd1-knockdown embryos, suppression of Hmgpi
expression continued until the blastocyst stage, whereas suppression
of Klf5 expression was relieved by the morula stage, when Klf5
expression recovered spontaneously. Accordingly, we hypothesized
that suppression of Hmgpi through the blastocyst accounts for







siControl 45 (3) 22 (48.9)
siChd1 45 (3) 6 (13.3)*
*P<0.05.
Fig. 4. Effects of Chd1-knockdown on global gene expression.
(A) Immunofluorescence detection of BrUTP incorporation as a measure
of genome-wide transcription in control and Chd1-knockdown embryos
(red, BrUTP; blue, chromatin). Twenty embryos were used in each experiment
(n=3): in total, 60 embryos each for siControl and siChd1. (B) Quantitation of
fluorescence signal intensity for BrUTP incorporation assay. The signal
intensity of BrUTP in the nuclei was individually quantitated. The signal
intensity of the nuclei in control embryos was defined as 1. Data are expressed
as means±s.e.m. (n=15).
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suppression of Pou5f1, Nanog and Cdx2 expression, normal ICM-
derived colony formation and the numbers of live offspring. Thus,
we investigated the effects of Hmgpi-rescue in Chd1-knockdown
embryos on Pou5f1, Nanog and Cdx2 expression and
postimplantation development. We observed that Pou5f1, Nanog
and Cdx2 expression, normal ICM-derived colony formation and
the numbers of live offspring were all restored in Chd1-knockdown-
Hmgpi-rescue embryos, suggesting that CHD1 plays important
roles as a trigger for Pou5f1, Nanog and Cdx2 expression through
the regulation of Hmgpi expression at ZGA. Furthermore, we
showed that the rescue of HMGPI had no effect on Klf5 expression
in Chd1-knockdown-Hmgpi-rescue embryos, suggesting that there
is no direct interaction between Hmgpi and Klf5 during
preimplantation development.
The maintenance of pluripotency depends on OCT4 and
NANOG functions during preimplantation development (Chen
et al., 2009; Mitsui et al., 2003; Nichols et al., 1998; Shao et al.,
2008). Pou5f1 and Nanog, both of which are ICM markers,
negatively interact with Cdx2, a TE marker, and these three genes
are key regulators in cell fate specification (Chen et al., 2009; Niwa
et al., 2005; Ralston et al., 2010; Strumpf et al., 2005). Pou5f1 or
Nanog knockout mouse embryos can develop into morphologically
normal blastocysts; however, developmental arrest occurs during
the postimplantation period due to a loss of pluripotency (Mitsui
et al., 2003; Nichols et al., 1998; Ralston et al., 2010). By contrast,
Cdx2 knockout mouse embryos are arrested at the early blastocyst
stage because they fail to maintain the blastocoel (Strumpf et al.,
2005). Therefore, it is possible that suppression of Pou5f1,
Nanog and Cdx2 could account for the exhibition of embryonic
lethality. Although Chd1-knockdown embryos can develop into
morphologically normal blastocysts despite suppression of Cdx2, it
is probable that low levels of remaining CDX2 protein might
function during TE development. Guzman-Ayala et al. (2015)
reported that CHD1 is required for the maintenance of the epiblast at
E5.5 (Guzman-Ayala et al., 2015); however, our results show that
CHD1 is required for the expression of Hmgpi at ZGA and that
Fig. 5. CHD1 is required for development of preimplantation embryos. qRT-PCR analysis of (A) Oct4, (B) Nanog and (C) Cdx2 mRNA in control and
Chd1-knockdown embryos from the early 2-cell to the blastocyst stages (*P<0.05). Expression levels were normalized to H2afz, used as internal control. mRNA
levels of the early 2-cell control embryos were defined as 1 for Oct4 and Nanog quantitation, and mRNA levels of the 8-cell control embryos were defined as
1 for Cdx2 quantitation. Data are expressed as means±s.e.m. (n=3). (D) Immunofluorescence detection of OCT4, NANOG and CDX2 in control and
Chd1-knockdown embryos (red, OCT4; red, NANOG; green, CDX2; blue, chromatin). Representative images of embryos at each stage are shown. Between 20
and 50 embryos were used in each experiment (OCT4 and CDX2 double-staining; n=3): in total, 122, 87, 88 and 134 control embryos and 97, 106, 142 and 178
Chd1-knockdown embryos each for 4-cell, 8-cell, morula and blastocyst stage, respectively. Between 20 and 30 embryos were used in each experiment (NANOG;
n=3): in total, 65, 60, 85 and 88 control embryos and 74, 68, 90 and 89 Chd1-knockdown embryos each for 4-cell, 8-cell, morula and blastocyst stage, respectively.
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global transcriptional activity is not changed at ZGA and MGA
in Chd1-knockdown embryos. These results suggest that
CHD1 selectively regulates transcription during mouse early
preimplantation development. Together, these results suggest that
CHD1 plays dual roles during embryogenesis: (1) resulting in
Hmgpi and Klf5 expressions at ZGA during preimplantation
development, and (2) acting as a regulator of global gene
expression after implantation.
Developmentally important genes are marked by H3K4me3 at
pre-ZGA and have a strong propensity to be activated after ZGA
(Lindeman et al., 2011). In this study, we demonstrated that CHD1,
a chromatin-remodeling factor that recognizes H3K4me3, is
involved in the regulation of gene expression at ZGA and affects
the development of mouse pre- and post-implantation embryos.
Therefore, to understand the regulatory mechanisms of early
embryogenesis, it is important to discern the transcriptional
mechanisms in which H3K4me3 is involved at ZGA.
In conclusion, we demonstrated that CHD1 regulates the
initiation of zygotic Oct4, Nanog and Cdx2 expression at MGA
via activation of Hmgpi and Klf5 expression at ZGA. Thereafter,
both HMGPI and KLF5, under the control of CHD1, regulate the
expression of Pou5f1, Nanog and Cdx2, and thereby control
initiation of cell fate specification. Subsequently, Klf5 expression
escapes from the control of CHD1, and HMGPI regulates the
expression of Pou5f1 and Nanog in the future ICM/EPI and the
expression of Cdx2 in the future TE.
MATERIALS AND METHODS
Superovulation, embryo collection and embryo culture
Eight- to ten-week-old ICR female mice (Japan SLC) were superovulated by
injecting 5 IU of equine chorionic gonadotropin (eCG; ASUKA), followed
by 5 IU of human chorionic gonadotropin (hCG; ASUKA) 48 h later.
Unfertilized eggs were harvested 14 h after the hCG injection and placed in a
90-μl droplet of HTF supplemented with 4 mg/ml BSA (A3311; Sigma-
Aldrich) (Minami et al., 2001). Spermatozoa were collected from the cauda
epididymis of11- to15-week-old ICRmalemice (JapanSLC) and cultured for
2 h in 100-μl of HTF supplemented with 4 mg/ml BSA. After preincubation,
sperm were introduced into fertilization droplets at a final concentration of
1×106 cells/ml.After a 3-h incubation, fertilized1-cell embryoswere collected
and washed three times in KSOM supplemented with amino acids (Ho et al.,
1995) and 4 mg/ml BSA, and then were either used for microinjection (39) or
cultured until embryonic day 4.5 (E4.5) in the samemediumundermineral oil
(Sigma-Aldrich) at 37°C in an atmosphere of 5% CO2.
Chd1 siRNA injection
Approximately 5-10 pl of 100 µM Chd1 siRNA (siChd1) (RNAi, Japan;
5′-GGUUUACUUAGGCGACAUUAA-3′) or the control scrambled sequence
siRNA (siControl; RNAi) (5′-GCGUUUAUAGCAUAUUGCGAA-3′) in
annealing buffer [consisting of 30 mM HEPES-KOH (pH 7.4), 100 mM
KOAc and 2 mMMg(OAc)2] was microinjected into the cytoplasm of 1-cell
embryos between 3 and 4 h after insemination. After injection, the embryos
were cultured in KSOMmedium supplemented with amino acids (Ho et al.,
1995) with 4 mg/ml BSA under mineral oil (Sigma-Aldrich) at 37°C in an
atmosphere of 5% CO2. To examine developmental competency and
hatching ability, embryos were observed at 36 (E1.5), 60 (E2.5), 84 (E3.5),
Fig. 6. Effects of Chd1-knockdown on Hmgpi
and Klf5 expression. qRT-PCR analyses of
(A) Hmgpi and (C) Klf5 mRNA in control and
Chd1-knockdown embryos from the early 2-cell to
the blastocyst stages (*P<0.05). Expression levels
were normalized to H2afz, used as an internal
control. The mRNA levels of the late 2-cell control
embryos were defined as 1. Data are expressed as
means±s.e.m. (n=3). (B) Immunofluorescence
detection of HMGPI in control andChd1-knockdown
embryos (green, HMGPI; blue, chromatin).
Representative images of embryos at each stage
are shown. Between 20 and 30 embryos were used
in each experiment (n=3): in total, 59, 75, 95 and
102 control embryos, and 76, 82, 75 and 114
Chd1-knockdown embryos each for 4-cell, 8-cell,
morula and blastocyst stage, respectively.
(D) Immunofluorescence detection of KLF5 in
control and Chd1-knockdown embryos (green,
KLF5; blue, chromatin). Representative images of
embryos at each stage are shown. Between 20 and
50 embryos were used in each experiment (n=3): in
total, 87, 59, 117 and 126 control embryos, and 90,
76, 122 and 144 Chd1-knockdown embryos each
for late 2-cell, 4-cell, 8-cell, morula and blastocyst
stage, respectively.
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108 (E4.5) and 132 h (E5.5) after insemination. Furthermore, the embryos
were harvested for quantitative RT-PCR (qRT-PCR), IF staining, outgrowth
analysis or embryo transfer.
RNA extraction and qRT-PCR
Embryos were harvested after culturing for 14, 20, 36, 48, 55, 76 and 108 h
after insemination, when most of the oocytes had reached the 1-cell, early 2-
cell, late 2-cell, 4-cell, 8-cell, morula and blastocyst stages, respectively.
RNA extraction and qRT-PCR were performed as described previously
(Suzuki et al., 2013). Total RNA from 30 embryos was extracted using
TRIzol (Invitrogen). Transcription levels were determined on three different
sets of 30 embryos per stage and normalized to H2afz, a stable reference
gene used for normalization of gene expression in mouse preimplantation
embryos (Jeong et al., 2005; Mamo et al., 2007); relative gene expression
was calculated using the 2−ΔΔCt method (Livak and Schmittgen, 2001). The
primers used for qPCR are listed in supplementary material Table S1.
IF staining
Embryos for immunostaining were collected as described above. For staining
of CHD1, HMGPI and KLF5, zona pellucida was removed from the embryo
by acid Tyrode’s solution (pH 2.5) and the embryos were fixed in phosphate
buffered saline (PBS) containing 4% paraformaldehyde (Sigma-Aldrich) for
Fig. 7. Effects of Hmgpi-rescue in Chd1-knockdown embryos on development of pre- and post-implantation embryos. (A) Photographs depict
representative results of outgrowth experiments from control and Chd1-knockdown-Hmgpi-rescue embryos. (B) Percentage of ICM-derived colony formation in
control andChd1-knockdown-Hmgpi-rescue embryos after 4 days in culture (*P<0.05). Data are expressed as means±s.e.m. (n=3). Between 20 and 80 embryos
were used in each experiment: in total, 172 and 129 embryos for siControl and siChd1 + HmgpimRNA, respectively. qRT-PCR analysis of (C) Chd1, (D) Pou5f1,
(E) Nanog and (F) Cdx2 mRNA in control, Chd1-knockdown and Chd1-knockdown-Hmgpi-rescue embryos from the late 2-cell to the blastocyst stages.
Expression levels were normalized to H2afz, used as internal control. The mRNA levels of the late 2-cell control embryos were defined as 1 for Chd1, Pou5f1
and Nanog quantitation, and mRNA levels of the 8-cell control embryos were defined as 1 for Cdx2 quantitation. Data are expressed as means±s.e.m. (n=3).
(G) Immunofluorescence detection of OCT4, NANOG and CDX2 in control, Chd1-knockdown and Chd1-knockdown-Hmgpi-rescue embryos (red, OCT4; red,
NANOG; green, CDX2; blue, chromatin). Representative images of embryos at each stage are shown. Between 20 and 50 embryos were used in each experiment
(OCT4 and CDX2 double-staining; n=3): in total, 122, 87, 88 and 134 control embryos, 97, 106, 142 and 178Chd1-knockdown embryos, and 93, 85, 137 and 155
Chd1-knockdown-Hmgpi-rescue embryos each for 4-cell, 8-cell, morula and blastocyst stage, respectively. Between 20 and 30 embryos were used in each
experiment (NANOG; n=3): in total, 60, 64, 82 and 81 control embryos, 66, 63, 79 and 77 Chd1-knockdown embryos, and 68, 62, 72 and 68 Chd1-knockdown-
Hmgpi-rescue embryos each for 4-cell, 8-cell, morula and blastocyst stage, respectively.
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20 min at 4°C. After washing three times in PBS containing 0.3%
polyvinylpyrrolidone (PVP K-30, Nacalai Tesque; PBS/PVP), embryos
were treated with 0.5% Triton X-100 (Sigma-Aldrich) in PBS for 40 min at
room temperature (RT), blocked in PBS containing 1.0% BSA (A9647,
Sigma-Aldrich) for 1 h at RT (for CHD1 and KLF5) or 3.0% BSA overnight
at 4°C (for HMGPI) and then incubated overnight at 4°C with a rabbit anti-
CHD1 antibody (1:25 dilution; #4351, Cell Signaling) or a rat anti-KLF5
antibody (1:500 dilution; Shindo et al., 2002) or for 1 h at RT with a rabbit
anti-HMGPI antibody (1:100 dilution; Yamada et al., 2010) in PBS
containing 1.0% BSA (PBS/BSA). After washing with PBS/BSA, embryos
were incubated in PBS/BSA containing a secondary antibody (Alexa Fluor
594 goat anti-rabbit IgG, 1:250 dilution, Invitrogen, R37117; Alexa Fluor
488 goat anti-rat IgG, 1:300 dilution, Invitrogen, A-11006; or Alexa Fluor
488 goat anti-rabbit IgG, 1:500 dilution, Invitrogen, A27034) for 1 h at RT.
After washing three times in PBS/BSA for 15 min each, nuclei were stained
in PBS/BSA containing 10 µg/ml Hoechst 33342 (Sigma-Aldrich) for
10 min. Immunostaining with normal rabbit IgG (sc-2027, Santa Cruz; 1:200
dilution) was included as a negative control for the specificity of the
anti-CHD1 antibody. For double-staining of OCT4 and CDX2,
immunofluorescence staining was performed as previously described (Isaji
et al., 2013). For NANOG staining, embryos were fixed in PBS containing
4% paraformaldehyde for 10 min at RT. After three washes in PBS/PVP,
fixed embryos were treated with 0.5% Triton X-100 (Sigma-Aldrich) in PBS
for 30 min at RT, blocked in PBS containing 10% fetal bovine serum and
0.1% Triton X-100 (PBS/FBS) for 1 h at RT. Next, embryos were incubated
overnight at 4°C with a rabbit anti-NANOG antibody (1:1000 dilution,
1 µg/ml; ab5731, Millipore) in PBS/FBS. Embryos were washed three times
in PBS/FBS and then incubated for 1 h at RT with the appropriate secondary
antibody diluted 1:750 (Alexa Fluor 594-conjugated goat anti-rabbit IgG,
Invitrogen, A-11037). After staining, the samples were washed three times in
PBS/BSA or PBS/FBS for 15 min, and nuclei were stained for 10 min at RT
in PBS containing 10 µg/ml Hoechst 33342 (Sigma-Aldrich). For staining
of BrUTP, immunofluorescence staining was performed as described
previously (Aoki et al., 1997). After IF staining, embryos were mounted
on slides in 50% glycerol/PBS and fluorescent signals were detected with a
fluorescence microscope (BX50, Olympus). At least 30 oocytes were
examined in each group. The numbers of ICM and TE cells were determined
by counting OCT4+ and CDX2+ cells, respectively. Total embryonic cell
numbers were obtained by adding the numbers determined for the ICM and
TE cells. To count the cell number and observe the localization of OCT4,
NANOG and CDX2 in Chd1-knockdown embryos, exposure time was
extended relative to that used for control embryos.
Outgrowth analysis
Outgrowth analysis was carried out on E3.5 embryos after removal of the
zona pellucida by acid Tyrode’s solution (pH 2.5). The embryos were
cultured in ES medium (Glasgow modification of Eagle’s medium/GMEM;
Invitrogen) supplemented with 10% fetal bovine serum (FBS), 1 mM
sodium pyruvate (Sigma), 0.1 mM MEM non-essential amino acid
(Invitrogen), 0.1 mM 2-mercaptoethanol (Wako), 0.1 mM L-glutamine,
100 U/ml penicillin and 100 μg/ml streptomycin (Invitrogen) on a 0.1%
gelatin-coated dish (Sigma-Aldrich) at 37°C in an atmosphere of 5% CO2.
After 4 days in culture, the embryos were photographed and the percentage
of blastocysts that had undergone outgrowth was calculated.
Embryo transfer
Fifteen embryos that reached the 2-cell stage after microinjection were
transferred into the oviducts of surrogate females (Japan SLC), which had
been mated with vasectomized males the day before embryo transfer. These
females were sacrificed at day 19 and pups were counted. The experiment
was repeated three times.
BrUTP incorporation assay
Embryos were harvested after culturing for 36 and 48 h after insemination,
when most of the oocytes reached the late 2- and 4-cell stages, respectively.
BrUTP incorporation assay was performed by electroporation using the
Super Electroporator NEPA 21 (NEPAGENE). Embryos werewashed twice
in PBS and then transferred in a line on the glass chamber between metal
plates filled with PBS containing 10 mM BrUTP (Sigma-Aldrich). The
poring pulse (voltage: 225 V, pulse length: 0.5 ms, pulse interval: 50 ms,
number of pulses: 4, +) and the transfer pulse (voltage: 20 V, pulse length:
50 ms, pulse interval: 50 ms, number of pulses: 5, ±) were selected. The
embryos were washed three times and cultured in KSOM supplemented
with amino acids (Ho et al., 1995) and 4 mg/ml BSA under mineral oil
(Sigma-Aldrich) at 37°C in an atmosphere of 5%CO2 for 1 h. Subsequently,
the embryos were treated with 0.2% Triton X-100 (Sigma-Aldrich) in PBS
for 3 min at RT after removal of the zona pellucida by acid Tyrode’s solution
(pH 2.5) and fixed in PBS containing 4% paraformaldehyde (Sigma-
Aldrich) overnight at 4°C. After washing three times in PBS/PVP, they were
subjected to immunostaining. BrUTP-related signals were observed using a
fluorescence microscope (BZ-X700, Keyence), and the fluorescence signal
intensity was quantitated by using measurement module BZ-H3C (Hybrid
Cell Count, Keyence).
In vitro transcription and microinjection
The Hmgpi ORF was generated by PCR from mouse embryonic stem cell
cDNA. For construction of an Hmgpi expression vector, the Hmgpi ORF
was digested by AgeI and BamHI, and the fragment was cloned into the
pAcGFP1-C1 vector plasmid (Clontech). The plasmid, digested by MluI,
was used as template for in vitro transcription. RNA synthesis and poly(A)
tailing were performed with a MEGAscript T7 kit (Invitrogen).
Approximately 5-10 pl of 100 ng/μl Hmgpi mRNA in DEPC water
(Invitrogen) was microinjected into the embryonic cytoplasm just after
microinjection of siChd1. The primers used for cloning are listed in
supplementary material Table S2.
Statistical analysis
Each experiment was repeated at least three times. All data are expressed as
means±s.e.m. Statistical analysis of the data was performed by analysis of
variance (ANOVA) with Student’s t-test. P-values <0.05 were considered to
be statistically significant.
Ethical approval for the use of animals
All animal experiments were approved by the Animal Research Committee
of Kyoto University (Permit number: 24-17) and performed in accordance
with the guidelines of the committee.
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siControl 45 (3) 20 (44.4)
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